Juvenile Diabetes Research Foundation

Recent papers from Juvenile Diabetes Research Foundation

1. Consensus Guideline DTECH: Technology for Glycemic Control in Type 1 DiabetesJournal of Diabetology · 2026
2. Use of Diabetes Technology at the Advanced AgeDiabetes Technology & Therapeutics · 2025
3. Machine learning techniques to predict diabetic ketoacidosis and HbA1c above 7% among individuals with type 1 diabetes — A large multi-centre study in Australia and New ZealandNutrition Metabolism and Cardiovascular Diseases · 2025
4. The top 10 priorities in adults living with type 1 diabetes in Ireland and the United Kingdom – A James Lind Alliance priority setting partnershipDiabetic Medicine · 2024
5. The optimal second-line therapy for older adults with type 2 diabetes mellitus: protocol for a systematic review and network meta-analysis using individual participant data (IPD)Systematic Reviews · 2024
6. Dichotomising the risk of hyperglycaemia into diabetes and prediabetes may render a disservice to patient careClinical Medicine · 2023
7. Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 DiabetesNew England Journal of Medicine · 2022
8. Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stageTyöväentutkimus Vuosikirja · 2022
9. Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrumInternal Medicine Journal · 2021
10. The top 10 research priorities in diabetes and pregnancy according to women, support networks and healthcare professionalsDiabetic Medicine · 2021
11. Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus GuidelinesThe journal of nutrition health & aging · 2020
12. Screening for and Managing the Person with Frailty in Primary Care: ICFSR Consensus GuidelinesThe journal of nutrition health & aging · 2020
13. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes DiagnosisThe Journal of Clinical Endocrinology & Metabolism · 2020
14. Proinsulin misfolding is an early event in the progression to type 2 diabeteseLife · 2019
15. Transforming mental well‐being for people with diabetes: research recommendations from Diabetes UK's 2019 Diabetes and Mental Well‐Being WorkshopDiabetic Medicine · 2019
16. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseJournal of Autoimmunity · 2018
17. The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosusArthritis Research & Therapy · 2018
18. Language matters. Addressing the use of language in the care of people with diabetes: position statement of the English Advisory GroupDiabetic Medicine · 2018
19. The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus2018
20. The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of ageDiabetologia · 2017